Highly reproducible, robust system—the exact same protocol has been shown to work across 25 different iPS cell lines, so no need to optimize for your lines.
Ideal for drug metabolism and safety studies—consistently generate panels of >90% pure, functional, hiPS cell-derived hepatocytes with diverse genetic backgrounds.
Customized starting materials—start with any disease-relevant iPS cell lines and create accurate liver disease models.
Ready for personalized medicine—make patient-specific, disease-specific cells for therapeutic applications.
Extended experimental window—hepatocytes can be used for a minimum of 11 days for functional tests.
Immunocytochemistry analysis of hepatocyte differentiation. hiPS cells were differentiated into functional hepatocytes using the Cellartis iPS Cell to Hepatocyte Differentiation System. Hepatocytes were immunostained to detect early hepatic markers HNF4α (red, nuclear) and CK18 (green) on days 14 and 21. As the hepatocytes matured, expression of liver-specific markers CYP3A (red, cytoplasmic) and Albumin (green) increased as seen on day 28, as expected. Cell nuclei were stained with DAPI (blue).
參考文獻:
Asplund, A., et al. (2015) Stem Cell Rev. and Rep. Advance online publication. doi: 10.1007/s12015-015-9621-9
訂購信息
品牌
貨號
產(chǎn)品描述
規(guī)格
Cellartis
Y30051
Cellartis® Hepatocyte Maintenance Medium
1(50 mlx2)
Cellartis
Y30055
Cellartis® iPS Cell to Hepatocyte Differentiation System